ETFS Holding Amgen Inc

 
ETFS Holding Amgen Inc top ^
  • Holdings: Top Holdings IBB More..., Regeneron Pharmaceuticals, Inc., Gilead Sciences Inc, Amgen Inc, Celgene Corporation, Biogen Idec Inc
  • Category: Health
  • Morningstar Rating: 4 Stars
Sign-up for ibb investment picks
  • Holdings: Top Holdings PKW More..., Oracle Corporation, ConocoPhillips, Amgen Inc, American International Group Inc, Time Warner Inc
  • Category: Large Blend
  • Morningstar Rating: 5 Stars
Sign-up for pkw investment picks
  • Holdings: Top Holdings BBH More..., Amgen Inc, Gilead Sciences Inc, Biogen Idec Inc, Celgene Corporation, Vertex Pharmaceuticals
  • Category: Health
Sign-up for bbh investment picks
  • Holdings: Top Holdings VHT More..., Johnson & Johnson, Pfizer Inc, Merck & Co Inc, Amgen Inc, Gilead Sciences Inc
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for vht investment picks

 
Stock Quotes for Amgen Inc top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
  • Morningstar Rating: 4 Stars
Sign-up for amgn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
  • Morningstar Rating: 4 Stars
Sign-up for amgn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Core
  • Stock Type: Slow Growth
Sign-up for amg%20n investment picks

 
News Articles for Amgen Inc top ^
2013/3/1
THOUSAND OAKS, Calif.
Sign-up for Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference investment picks
2013/2/5
ADVISORY, Feb.
Sign-up for Amgen Inc. [AMGN] to Ring The NASDAQ Stock Market Opening Bell investment picks
2013/1/31
THOUSAND OAKS, Calif.
Sign-up for Amgen To Webcast 2013 Business Review Meeting On February 7 investment picks
2013/2/22
THOUSAND OAKS, Calif.
Sign-up for Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients investment picks
2013/2/8
Four Inspirational Individuals Making a Positive Impact for Those Affected by Cancer to be Honored at the Amgen Tour of California THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Call For Nominations For 2013 Breakaway From Cancer® Champions investment picks
2013/2/7
Amgen Emphasizes Pipeline, International Expansion and Biosimilars as Growth Drivers Pivotal Data from Eight Late-Stage Programs Anticipated Between 2013 and 2016 NEW YORK , Feb.
Sign-up for Amgen Outlines Long-Term Strategy investment picks
2013/3/20
PsiOxus Therapeutics today issued a statement in response to initial results from Amgen's (Nasdaq: AMGN) phase III study of talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV metastatic melanoma compared to treatment with subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF). Talimogene laherparepvec is a novel oncolytic vaccine that represents a new class of anticancer agents known as oncolytic vaccines.
Sign-up for PsiOxus Therapeutics Comments on Phase III Results from Amgen’s Oncolytic Vaccine investment picks
2013/3/19
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma investment picks
2013/4/16
--Settlement resolves whistleblower lawsuit related to sales of Aranesp --
Sign-up for UPDATE: Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks investment picks
2013/4/16
Amgen Inc. (AMGN) will pay $24.9 million to settle allegations that it paid kickbacks to certain long-term care pharmacy providers, the Justice Department said.
Sign-up for Amgen to Pay $24.9 Million to Settle Kickbacks Allegations investment picks
2013/4/16
Amgen Inc. (AMGN) will pay $24.9 million to settle allegations that it paid kickbacks to certain long-term care pharmacy providers, the Justice Department said.
Sign-up for Amgen to Pay $24.9 Million to Settle U.S. Allegations of Kickbacks investment picks
2013/4/18
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Webcast of 2013 First Quarter Financial Results investment picks
2013/4/23
-- Amgen's profit jumps 21%, bolstered by a lower tax rate --Revenue falls short of analysts' expectations --International sales up 8% Amgen Inc.'s (AMGN) first-quarter earnings rose 21% as a significantly lower tax rate offset disappointing sales, especially of its key arthritis and osteoporosis drug.
Sign-up for Amgen Sales Disappoint as Profits Jump 21% investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Amgen Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Ametek, Inc.  |  Next: ETFS Holding Amphenol Corp